Is HEXO “Too Quebec to Fail?”

Interested in investing in cannabis? Find out what makes Hexo Corp. (TSX:HEXO) stand out amongst its peers.

| More on:
question marks written reminders tickets

Image source: Getty Images

I’m sorry, I just love the term “too Quebec to fail.”

Looking at a number of darling companies that have come out of Quebec, one can certainly make the argument that Quebec-based companies have the uncanny ability to pick up cheap government financing or equity injections right when they’re needed.

Here’s my take on why and how this might impact Quebec-based Hexo Corp. (TSX:HEXO) moving forward.

Hexo’s financial quandary

Similar to most cannabis producers, Hexo has been absolutely ravished by the stock market over the past year. Hexo was one of the first producers to announce layoffs, and has run into a litany of production problems which have stunted any attempts the market tried to make to push the company’s share price higher.

The problems continue to pile on every week, it seems. Most investors have exited the fray, viewing Hexo as too risky.

Here’s why I think they’re wrong.

A (financial) hero for Hexo

Hexo has secured a serious chunk of provincial contracts in Quebec to sell cannabis to the provincial buyer. For a relatively small producer, this has been huge for investor confidence initially.

With the rollout of physical locations across Canada disappointing the cannabis sector, and specifically investors, questions remain as to just how much of the contracted amount Hexo will be able to sell through legal marijuana channels in Quebec.

That said, investors can bank on the Quebec government stepping in and buying weed from Hexo to prop the company up, even if the province has to throw away the product and taxpayers are forced to eat the cost.

The Quebec government will want to have a favourite child to point to in the cannabis sector. Right now, that’s Hexo.

The big question for many, however, is whether Hexo will have the ability to ramp up and produce larger amounts in such a scenario.

Demand hasn’t been what was expected by investors. Obviously, most cannabis consumption estimates pre-legalization were ridiculous. Thus, Hexo has been forced to lay off workers en masse and close down underperforming facilities.

While I’m in the camp that believes these moves were prudent financial decisions that needed to be made for Hexo to survive, it will be interesting to see what would happen in the scenario described above.

Bottom line

With so many cannabis companies in dire straights now due to a lack of financial discipline in 2017 and 2018, I do believe we’ll start to see bankruptcies this year.

That said, I have this funny feeling that Hexo might find a way to hang on — perhaps with a little help — for a lot longer than some of its competitors.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. Fool contributor Chris MacDonald does not have ownership in any stocks mentioned in this article.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »